Nishant Babaria

Co-Founder & CEO

Nishant Babaria received his undergraduate degree in Biomedical Engineering from The University of Texas at Austin. He is pursuing a M.S. degree in Electrical and Computer Engineering at Purdue. He has previous experience developing medical devices from undergraduate research at UT Austin and from working alongside the Corporate R&D team at Smith and Nephew.

Ranajay Mandal

Co-Founder & Vice President

Ranajay Mandal received his Bachelor’s degree in Electrical Engineering from Indian Institute of Technology, Kharagpur, India. He also received his Master’s degree with a specialization in Instrumentation and Signal Processing from IIT KGP. He is pursuing his PhD in Biomedical Engineering at Purdue University and has multiple years of research experience in design, development and fabrication of biomedical devices.

Dr. Zhongming Liu

Co-Founder & President

Dr. Zhongming Liu is an assistant professor in the Weldon School of Biomedical Engineering, the School of Electrical and Computer Engineering at Purdue University. He received his B.S. and M.S. degrees in electrical engineering from Zhejiang University in China. He received his Ph.D degree in biomedical engineering from the University of Minnesota at Twin Cities in USA. Before joining Purdue, he was a research fellow in Advanced MRI section, Laboratory of Functional and Molecular Imaging at the National Institutes of Health. His primary research interest is imaging, stimulating, and modeling the brain for advancing neuroscience and artificial intelligence.


MR-Link aims to deliver novel medical devices for physiological recording and stimulation during concurrent magnetic resonance imaging (MRI) based on technologies developed at Purdue University. Imaging, recording, and stimulation are complementary ways to study the structures, functions, and pathologies of the brain. Our products are unique, affordable, and offer a scalable solution to integrate multiple diagnostic imaging techniques and their respective benefits. The company’s long-term goal is developing its technology to deliver an affordable and MRI-compatible EEG system to the clinical human market. The path the company will take to reach this goal is to primarily cater its products to the animal research market to refine the technology for clinical trials, FDA approval process, and ultimately meet the standard required in the clinical setting for human subjects. We at MR-Link believe that our technology will accelerate the progress in the understanding, diagnosis, and prevention of various brain disorders and enable researchers and clinicians to develop novel treatment plans with improved success rates and a better quality of care for patients. Recently, MR-Link received a Federal grant from NIH, an STTR for $230K, to develop their technology.


General Interest